DR RASOULI
ActiveDR RASOULI has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.07M and a net result of €371k. Equity is growing by ~7.6% per year across the filed fiscal years. Its solvency ranks better than 81% of 90 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
93
/ 100
Excellent▼ -7 vs 2024
The score combines four axes.
Axes · tick = 2024
Profitability89▼-11
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €190k at 30 days acceptable
Liquidity ample (current ratio 8.97 against 8.99 in 2024), and 10.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
6 signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
89.6%
Return on assets
16%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
46 d early
2024
31 d early
2023
33 d early
2022
25 d late
2021
30 d late
2020
30 d late
2019
28 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
04-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€2.07M▲ 7.0%
2024 · €1.94M
2023: €1.78M
2024: €1.94M
2023 → 2025
Total assets
€2.32M▲ 7.2%
2024 · €2.16M
2023: €1.88M
2024: €2.16M
2023 → 2025
Net result
€371k▼ 5.6%
2024 · €393k
2023: €342k
2024: €393k
2023 → 2025
Working capital
€1.92M▲ 8.5%
2024 · €1.77M
2023: €1.60M
2024: €1.77M
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€1.78M-€1.94M▲ 9.1%€2.07M▲ 7.0%
Operating result€470k-€530k▲ 12.8%€512k▼ 3.4%
Net result€342k-€393k▲ 14.9%€371k▼ 5.6%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 3% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.32M
Fixed assets
€156k▼ 8.3%
Current assets
€2.16M▲ 8.5%
Equity and liabilities €2.32M
Equity
€2.07M▲ 7.0%
Debt
€241k▲ 8.8%
The debt ratio rises from 10.2% to 10.4%: debt grows faster than equity.
Key figures and ratios
EBITDA
€535k▼
2024 · €549k
Cash flow
€394k▼
2024 · €411k
Solvency
89.6%▼
2024 · 89.8%
Current ratio
8.97▼
2024 · 8.99
Quick ratio
8.97▼
2024 · 8.99
Debt / equity
0.12▲
2024 · 0.11
ROE
17.9%▼
2024 · 20.2%
ROA
16.0%▼
2024 · 18.2%
Interest coverage
129.82▼
2024 · 165.16
Debt
€241k▲
2024 · €221k
Debt ≤ 1 year
€241k▲
2024 · €221k
Income taxes
€171k▼
2024 · €183k
Staff costs
€168k▲
2024 · €165k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Total assets
20/58€2.32M
Fixed assets
21/28€156k
Tangible fixed assets
22/27€156k
Current assets
29/58€2.16M
Amounts receivable within one year
40/41€439k
Investments
50/53€1.06M
Cash & bank
54/58€656k
Total equity & liabilities
10/49€2.32M
Equity
10/15€2.07M
Contributions / capital
10/11€13k
Reserves
13€2.06M
Accumulated profits (losses)
14€0
Amounts payable
17/49€241k
Amounts payable within one year
42/48€241k
Trade debts payable within one year
44€16k
Income statement
Code2025
Gross operating margin
9900€707k
Operating result
9901€512k
Financial income
75€34k
Financial charges
65€4k
Result before taxes
9903€542k
Income taxes
67/77€171k
Net result for the period
9904€371k
Result to be appropriated
9905€371k
This is the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan.
See plans →
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Equity above €2MEq €2.07M ▲7%
3 profitable years in a row build equity to €2.07M.
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2023net €393k ▲14.9%
Operating result €530k, net result €393k, both a record.
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
25-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 25 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 30 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 30 days late
2020
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 28 days late
2019
28-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 28 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 31 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Comparable companies · same sector, comparable size
Similar companies · same sector, comparable size
DOKTER VEERLE PEETERS
BE 0473.303.679
Zonhoven · Eq €2.07M
DOKTER J. VAN LIERDE
BE 0456.393.413
Genk · Eq €2.07M
DOCTEUR BLAISE PIERRE
BE 0837.613.608
Verviers · Eq €2.08M
DR. STEFAN ORIS
BE 0458.600.162
Herentals · Eq €2.08M
MICRUROL
BE 0818.627.342
Herentals · Eq €2.08M
Of 16,632 companies in sector 86220 we hold annual accounts for 7,875. 4,536 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-01-2005
Fiscal year end31-12
Activities, NACEBEL
85120
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Data from official sources, last processed on 09-08-2026. Scores and ratios are computed by Checked and are not a credit decision.